Many organizations, from government agencies to philanthropic institutions and aid organizations, now demand that programs and policies be “evidence-based.” But the way this idea is being implemented ...
A first-in-human trial of intravesical BH011, a novel docetaxel formulation, in patients with high risk non-muscle invasive bladder cancer (HR-NMIBC) after BCG failure: Results from a phase 1 study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results